Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ

About this update from Indivior Pharmaceuticals, Inc.

[{"type":"image","alt":"Indivior Pharmaceuticals Inc.","displaySize":"","headline":null,"caption":"Indivior Pharmaceuticals Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":281,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/e9d504c29522664dffe10f903e7d96cc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WeCpCs6SY8iYoZekiVnfSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e9d504c29522664dffe10f903e7d96cc","width":281,"height":79}},"lazy":false},{"type":"text","content":"RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m. U.S. EST. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EST.","length":441,"tagName":"p"},{"type":"text","content":"Access to the Live Webcast Presentation:","length":40,"tagName":"p"},{"type":"text","content":"The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.","length":144,"tagName":"p"},{"type":"text","content":"Live webcast link: https://edge.media-server.com/mmc/p/f78ufsat","length":63,"tagName":"p"},{"type":"text","content":"Participants may access the presentation telephonically by registering with the following link:","length":95,"tagName":"p"},{"type":"text","content":"https://register-conf.media-server.com/register/BI44fe43e28e334eb58b41edf49f6f80ce","length":82,"tagName":"p"},{"type":"text","content":"(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)","length":169,"tagName":"p"},{"type":"text","content":"A replay of the presentation will be available at www.indivior.com.","length":67,"tagName":"p"},{"type":"text","content":"About Indivior As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have re...

More updates from Indivior Pharmaceuticals, Inc.